Effective new cancer drugs ‘held just out of reach’ of patients in Wales and Scotland,says cancer charity, after Roche prick deal with special fund in EnglandWomen with advanced breast cancer in Wales are to be deprived of a drug that could give them at least six months longer to live, and because the high price makes it unaffordable for the NHS.
The National Institute for Health and Care Excellence (kind) says in its final guidance to the NHS that Kadcyla is too expensive. The decision in effect sets up a postcode lottery in the UK because a special government fund will continue footing the bill for women who need it in England. Related: Andrew Lansley takes post advising drugs firm involved in dispute with NHS Continue reading...
Source: theguardian.com